Cryptolepine, a Plant Alkaloid, Inhibits the Growth of Non-Melanoma Skin Cancer Cells Through Inhibition of Topoisomerase and Induction of DNA Damage

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2016 Dec 24

PMID 28009843

Citations 19

Authors

Harish C Pal

Santosh K Katiyar

Affiliations

Soon will be listed here.

Abstract

Topoisomerases have been shown to have roles in cancer progression. Here, we have examined the effect of cryptolepine, a plant alkaloid, on the growth of human non-melanoma skin cancer cells (NMSCC) and underlying mechanism of action. For this purpose SCC-13 and A431 cell lines were used as an in vitro model. Our study reveals that SCC-13 and A431 cells express higher levels as well as activity of topoisomerase (Topo I and Topo II) compared with normal human epidermal keratinocytes. Treatment of NMSCC with cryptolepine (2.5, 5.0 and 7.5 µM) for 24 h resulted in marked decrease in topoisomerase activity, which was associated with substantial DNA damage as detected by the comet assay. Cryptolepine induced DNA damage resulted in: (i) an increase in the phosphorylation of ATM/ATR, BRCA1, Chk1/Chk2 and γH2AX; (ii) activation of p53 signaling cascade, including enhanced protein expressions of p16 and p21; (iii) downregulation of cyclin-dependent kinases, cyclin D1, cyclin A, cyclin E and proteins involved in cell division (e.g., Cdc25a and Cdc25b) leading to cell cycle arrest at S-phase; and (iv) mitochondrial membrane potential was disrupted and cytochrome c released. These changes in NMSCC by cryptolepine resulted in significant reduction in cell viability, colony formation and increase in apoptotic cell death.

Citing Articles

Fabrication and In Vivo Evaluation of In Situ pH-Sensitive Hydrogel of Sonidegib-Invasomes via Intratumoral Delivery for Basal Cell Skin Cancer Management.

Ghalwash M, Fouad A, Mohammed N, Nagib M, Khalil S, Belal A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861094 PMC: 11769384. DOI: 10.3390/ph18010031.

Role of Phytoconstituents in Cancer Treatment: A Review.

Kumar M, Gupta S, Kalia K, Kumar D Recent Adv Food Nutr Agric. 2024; 15(2):115-137.

PMID: 38369892 DOI: 10.2174/012772574X274566231220051254.

Natural Compounds in Non-Melanoma Skin Cancer: Prevention and Treatment.

Kowalski S, Karska J, Tota M, Skinderowicz K, Kulbacka J, Drag-Zalesinska M Molecules. 2024; 29(3).

PMID: 38338469 PMC: 10856721. DOI: 10.3390/molecules29030728.

Cryptolepine Analog Exhibits Antitumor Activity against Ehrlich Ascites Carcinoma Cells in Mice Targeting Cell Growth, Oxidative Stress, and PTEN/Akt/mTOR Signaling Pathway.

El-Aarag B, Shalaan E, Ahmed A, Sayed I, Ibrahim W Anticancer Agents Med Chem. 2024; 24(6):436-442.

PMID: 38305388 DOI: 10.2174/0118715206274318231128072821.

Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications.

Ding J, Ding X, Liao W, Lu Z Mater Today Bio. 2024; 24:100913.

PMID: 38188647 PMC: 10767221. DOI: 10.1016/j.mtbio.2023.100913.

References

Smith G, Divecha N, Lakin N, Jackson S . DNA-dependent protein kinase and related proteins. Biochem Soc Symp. 1999; 64:91-104. View

Dassonneville L, Bonjean K, De Pauw-Gillet M, Colson P, Houssier C, Quetin-Leclercq J . Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine. Biochemistry. 1999; 38(24):7719-26. DOI: 10.1021/bi990094t. View

Schuler M, Bossy-Wetzel E, Goldstein J, Fitzgerald P, Green D . p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem. 2000; 275(10):7337-42. DOI: 10.1074/jbc.275.10.7337. View

Morris E, Keramaris E, Rideout H, Slack R, Dyson N, Stefanis L . Cyclin-dependent kinases and P53 pathways are activated independently and mediate Bax activation in neurons after DNA damage. J Neurosci. 2001; 21(14):5017-26. PMC: 6762857. View

Benchimol S . p53-dependent pathways of apoptosis. Cell Death Differ. 2001; 8(11):1049-51. DOI: 10.1038/sj.cdd.4400918. View

Lisgarten J, Coll M, Portugal J, Wright C, Aymami J . The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites. Nat Struct Biol. 2001; 9(1):57-60. DOI: 10.1038/nsb729. View

Wang J . Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol. 2002; 3(6):430-40. DOI: 10.1038/nrm831. View

Xiao Z, Chen Z, Gunasekera A, Sowin T, Rosenberg S, Fesik S . Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. J Biol Chem. 2003; 278(24):21767-73. DOI: 10.1074/jbc.M300229200. View

Gibbons S, Fallah F, Wright C . Cryptolepine hydrochloride: a potent antimycobacterial alkaloid derived from Cryptolepis sanguinolenta. Phytother Res. 2003; 17(4):434-6. DOI: 10.1002/ptr.1284. View

10.

Chipuk J, Kuwana T, Bouchier-Hayes L, Droin N, Newmeyer D, Schuler M . Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004; 303(5660):1010-4. DOI: 10.1126/science.1092734. View

11.

Luo J, Li M, Tang Y, Laszkowska M, Roeder R, Gu W . Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A. 2004; 101(8):2259-64. PMC: 356938. DOI: 10.1073/pnas.0308762101. View

12.

Busino L, Chiesa M, Draetta G, Donzelli M . Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene. 2004; 23(11):2050-6. DOI: 10.1038/sj.onc.1207394. View

13.

Norbury C, Zhivotovsky B . DNA damage-induced apoptosis. Oncogene. 2004; 23(16):2797-808. DOI: 10.1038/sj.onc.1207532. View

14.

Thompson T, Tovar C, Yang H, Carvajal D, Vu B, Xu Q . Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J Biol Chem. 2004; 279(51):53015-22. DOI: 10.1074/jbc.M410233200. View

15.

Ansah C, Khan A, Gooderham N . In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine. Toxicology. 2005; 208(1):141-7. DOI: 10.1016/j.tox.2004.11.026. View

16.

He G, Siddik Z, Huang Z, Wang R, Koomen J, Kobayashi R . Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene. 2005; 24(18):2929-43. DOI: 10.1038/sj.onc.1208474. View

17.

Zhu H, Gooderham N . Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma a549 cells. Toxicol Sci. 2006; 91(1):132-9. DOI: 10.1093/toxsci/kfj146. View

18.

Gogvadze V, Orrenius S, Zhivotovsky B . Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim Biophys Acta. 2006; 1757(5-6):639-47. DOI: 10.1016/j.bbabio.2006.03.016. View

19.

Pommier Y . Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer. 2006; 6(10):789-802. DOI: 10.1038/nrc1977. View

20.

Olajide O, Heiss E, Schachner D, Wright C, Vollmar A, Dirsch V . Synthetic cryptolepine inhibits DNA binding of NF-kappaB. Bioorg Med Chem. 2006; 15(1):43-9. DOI: 10.1016/j.bmc.2006.10.018. View